Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesTransplantMHN Pediatric Kidney Transplant Coverage Update | …
    Ask Trek AI about this page
    CurrentmhnPolicy CP.MP.246

    Pediatric Kidney Transplant

    Customize your policy alerts

    Sign up for mhn Policy CP.MP.246 alerts

    Get alerted when Policy CP.MP.246 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Medical necessity criteria and coverage guidance for pediatric (age <18) kidney transplantation for non‑Medicare health plans affiliated with Centene, including candidate eligibility and contraindications.

    Policy Summary
    Payermhn
    PolicyPediatric Kidney Transplant
    Policy CodePolicy CP.MP.246
    Change TypeCriteria revisions and clarifications
    Effective Date
    Next Review Date
    Key ActionObtain prior authorization per plan procedures and include documentation of advanced renal disease (GFR thresholds) and absence of listed contraindications, including CD4 count and ART history for HIV‑infected candidates.
    SourceLink
    POLICY UPDATE CHANGES

    Criteria I.A.1. updated from GFR ≤ 15 mL/min/1.73 m2 to GFR < 15 mL/min/1.73 m2 to align with KDIGO and OPTN guidance.

    Criteria I.A.2. updated to include CKD stage 4 with GFR < 30 mL/min/1.73 m2 in members expected to reach ESRD.

    Contraindication I.B.2 for HIV infection clarified to require CD4 >200 cells/mm3, absence of active AIDS-defining opportunistic infection, and effective ART.

    Policy specifies that it applies to non‑Medicare health plans and refers Medicare criteria to a separate Medicare policy (MC.CP.MP.246).

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    age <18applicable age
    GFR <15ESRD threshold
    GFR <30CKD4 threshold
    11contraindication items

    Coverage and Medical Necessity Criteria

    Initial transplant candidacy

    Covered when ALL of the following are met:

    Primary eligibility

    • Advanced renal disease: One of: ESRD (stage 5) with GFR < 15 mL/min/1.73 m2 OR CKD stage 4 with GFR < 30 mL/min/1.73 m2 in those expected to reach ESRD
    • No contraindications: Does not have any contraindication from list I.B
    Advanced renal disease details: ESRD (stage 5) with GFR < 15 OR CKD stage 4 with GFR <30 when expected to progress to ESRD

    Patients with decompensated cirrhosis are excluded from pediatric kidney transplantation under this policy, unless they are evaluated and listed as candidates for a combined liver–kidney transplant.

    Transplantation is considered not medically necessary when the candidate has any of the listed active or uncontrolled conditions. Examples include active untreated infection (except treated hepatitis C where applicable), uncontrolled HIV (see HIV-specific control criteria), active malignancy with high risk of recurrence or death, recent stroke or transient ischemic attack within specified timeframes, active symptomatic cardiac or peripheral arterial disease that is unevaluated or unmanaged, inability to adhere to required post‑transplant regimens, active substance use disorder affecting decision‑making, recent acute pancreatitis within 3 months, or elevated circulating anti‑GBM antibodies.

    Candidate Selection Criteria

    Candidate selection criteria

    Candidate eligibility requires meeting renal function thresholds and absence of contraindications.

    Candidate basic criteria: Age <18 AND advanced renal disease defined by GFR thresholds (ESRD with GFR <15 mL/min/1.73 m2 OR CKD stage 4 with GFR <30 mL/min/1.73 m2 when expected to reach ESRD)
    HIV-specific criteria: For candidates with HIV: CD4 > 200 cells/mm3 AND absence of active AIDS-defining opportunistic infection AND currently on effective antiretroviral therapy (ART)

    Absolute and Relative Contraindications

    Contraindications that preclude transplantation include: active infection that is not properly treated (except hepatitis C), HIV infection with detectable viral load unless the candidate meets all three control criteria (CD4 > 200 cells/mm3, absence of active AIDS‑defining opportunistic infection, and evidence of being on effective antiretroviral therapy), active malignancy with high risk of recurrence or mortality, stroke within the past 6 months or transient ischemic attack within the past 3 months, active symptomatic cardiac disease not evaluated by a cardiologist, active symptomatic peripheral arterial disease not properly managed, inability to adhere to the regimen necessary to preserve the transplant even with caregiver support, active or ongoing substance use disorder that increases post‑transplant risk, acute pancreatitis within the last 3 months, decompensated cirrhosis (unless a combined liver–kidney transplant candidate), and elevated circulating anti‑glomerular basement membrane antibodies.

    Pre-Transplant Evaluation Requirements

    Prior Authorization

    Pre‑transplant multidisciplinary evaluation and referral; include procedure codes for authorization

    Refer pediatric patients with rapidly progressive CKD or anticipated progression to ESRD for multidisciplinary transplant evaluation to determine the cause of ESRD and suitability for transplantation. The evaluation should follow KDIGO and OPTN guidance and include specialty assessments (for example cardiology clearance when indicated) and documentation of renal function (GFR) thresholds. Providers must obtain prior authorization using the procedure codes referenced in the policy when scheduling donor/allograft procurement or transplantation services.

    • Refer patients with GFR <30 mL/min/1.73 m2 who are expected to progress to ESRD for transplant evaluation (CKD stage 4 eligibility context).
    • For ESRD (stage 5) document GFR <15 mL/min/1.73 m2.
    • Follow multidisciplinary center evaluation per KDIGO/OPTN guidance; obtain cardiology clearance after myocardial infarction when applicable.
    • When requesting authorization include the referenced procedure codes (50300, 50320, 50323, 50325, 50327, 50328, 50329, 50360, 50365, 50547, S2152) as applicable to donor procurement, backbench preparation, reconstruction, nephrectomy, implantation, and global transplant services.

    Provider Actions, Documentation, and Prior Authorization

    Billing Rule

    Prior authorization and referenced procedure codes

    Prior authorization is required per plan procedures for pediatric kidney transplant services; CPT and HCPCS procedure codes referenced in the policy should be used for informational coding guidance when requesting authorization.

    • Referenced procedure codes: 50300, 50320, 50323, 50325, 50327, 50328, 50329, 50360, 50365, 50547, S2152.
    • Providers should follow plan-specific prior authorization procedures and submit appropriate CPT/HCPCS codes for review.
    Step Therapy

    No step‑therapy requirement

    Step therapy does not apply; transplant candidacy is determined by meeting the clinical criteria in the policy rather than by a stepwise medication or therapy sequence.

    Procedure and Diagnosis Coding

    Referenced CPT/HCPCS Codesmixed
    50300Donor nephrectomy (including cold preservation); from cadaver donor, unilateral or bilateral.
    50320Donor nephrectomy (including cold preservation); open, from living donor.
    50323Backbench standard preparation of cadaver donor renal allograft prior to transplantation, including dissection and removal of perinephric fat, diaphragmatic and retroperitoneal attachments, excision of adrenal gland, and preparation of ureter(s), renal vein(s), and renal artery(s), ligating branches, as necessary.
    50325Backbench standard preparation of living donor renal allograft (open or laparoscopic) prior to transplantation, including dissection and removal of perinephric fat and preparation of ureter(s), renal vein(s), and renal artery(s), ligating branches, as necessary.
    50327Backbench reconstruction of cadaver or living donor renal allograft prior to transplantation; venous anastomosis, each.
    50328Backbench reconstruction of cadaver or living donor renal allograft prior to transplantation; arterial anastomosis, each.
    50329Backbench reconstruction of cadaver or living donor renal allograft prior to transplantation; ureteral anastomosis, each.
    50360Renal allotransplantation, implantation of graft; without recipient nephrectomy.
    50365Renal allotransplantation, implantation of graft; with recipient nephrectomy.
    50547Laparoscopy, surgical; donor nephrectomy (including cold preservation), from living donor.
    1–10 of 11
    1/2
    GFR thresholds for transplant candidacy
    ESRD thresholdGFR < 15 mL/min/1.73 m2 (stage 5 CKD)
    CKD stage 4 threshold (eligibility context)GFR < 30 mL/min/1.73 m2 for candidates expected to reach ESRD
    Rapidly progressing CKDPatients with GFR > 30 mL/min/1.73 m2 who are rapidly progressing toward ESRD should be referred for transplant evaluation

    Definitions and Terminology

    ESRD definition
    DefinitionEnd-stage renal disease (ESRD) = stage 5 CKD with GFR < 15 mL/min/1.73 m2
    Policy applicabilityUsed as one of the advanced renal disease criteria for pediatric transplant candidacy (age <18)
    AlignmentCriterion updated to GFR < 15 mL/min/1.73 m2 to align with KDIGO and OPTN guidance
    CKD stage 4 — eligibility context
    CKD stage 4 thresholdGFR < 30 mL/min/1.73 m2 for candidates expected to reach ESRD
    Role in eligibilityStage 4 CKD with this GFR is accepted when the member is expected to progress to ESRD
    Evaluation recommendation

    Transplant Center Expectations

    Note

    Center capabilities and guideline‑based evaluation

    Transplant centers are expected to perform guideline‑based, multidisciplinary evaluation and management per KDIGO and OPTN guidance; centers should have capabilities to evaluate etiology, comorbid conditions, and provide necessary pre‑ and post‑transplant care.

    • Evaluation and management recommendations are based on KDIGO 2020 and OPTN educational guidance.
    • Centers should assess cause of ESRD, cardiovascular risk, infection status, and other contraindications as part of multidisciplinary evaluation.

    Post-Transplant Services and Global Care

    Global transplant care and post-transplant services
    HCPCS S2152 global definitionS2152 covers procurement, transplantation, related complications, drugs, supplies, hospitalization with outpatient follow-up, medical/surgical/diagnostic/emergency/rehabilitative services, and the number of pre- and posttransplant care days in the global definition
    Post-transplant servicesPost-transplant care is included in the global transplant definition and should follow the plan's benefit terms for included pre- and post-transplant care days
    Care components referencedGlobal transplant care includes procurement, transplantation, and related complications plus associated services and follow-up

    Background and Rationale

    Kidney transplantation is the preferred treatment option for pediatric patients with advanced CKD and ESRD because it improves survival, quality of life, and growth—benefits that are particularly important in young children and in candidates for preemptive transplant when a living donor is available. A multidisciplinary evaluation should determine the etiology of ESRD and candidacy for transplant, and preemptive living‑donor transplantation is preferred when feasible.

    Policy Summary
    Payermhn
    PolicyPediatric Kidney Transplant
    Policy CodePolicy CP.MP.246
    Change TypeCriteria revisions and clarifications
    Effective Date
    Next Review Date
    Key ActionObtain prior authorization per plan procedures and include documentation of advanced renal disease (GFR thresholds) and absence of listed contraindications, including CD4 count and ART history for HIV‑infected candidates.
    SourceLink
    On This Page
    Coverage and Medical Necessity CriteriaCandidate Selection CriteriaAbsolute and Relative ContraindicationsPre-Transplant Evaluation RequirementsProvider Actions, Documentation, and Prior AuthorizationProcedure and Diagnosis CodingDefinitions and TerminologyTransplant Center ExpectationsPost-Transplant Services and Global CareBackground and Rationale
    Documentation Required

    Required supporting clinical documentation

    Submit clinical documentation demonstrating advanced renal disease using the policy GFR thresholds and evidence that no contraindications from the policy list are present; for candidates with HIV include CD4 >200 cells/mm3, absence of active AIDS‑defining opportunistic infection, and evidence of effective antiretroviral therapy.

    • Document GFR consistent with ESRD (GFR < 15 mL/min/1.73 m2) or CKD stage 4 (GFR < 30 mL/min/1.73 m2) when expected to reach ESRD.
    • For HIV: include recent CD4 count, documentation of no active AIDS‑defining infection, and current effective ART.
    Denial Risk

    Contraindications that may result in denial

    Presence of any listed active or uncontrolled conditions may lead to denial of transplant; ensure these are evaluated, treated, or documented as resolved before authorization.

    • Active untreated infection (except treated HCV).
    • Uncontrolled HIV without meeting specified control criteria.
    • Active malignancy with high risk of recurrence or death.
    • Recent stroke (within 6 months) or TIA (within 3 months).
    • Active symptomatic cardiac or peripheral arterial disease not evaluated/managed.
    • Inability to adhere to post‑transplant regimen, active substance use disorder, recent acute pancreatitis (<3 months), decompensated cirrhosis (unless combined transplant), or elevated anti‑GBM antibodies.
    Refer rapidly progressing patients (even if GFR >30) for transplant evaluation